Osaic Holdings
NPCE icon

Osaic Holdings’s Neuropace NPCE Stock Holding History

Osaic Holdings’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08K Buy
131
+47
+56% +$756 ﹤0.01% 7264
2026
Q1 		$1.1K Buy
+84
New +$1.26K ﹤0.01% 7236
2024
Q1 		– Sell
-233
Closed -$2.4K – 7334
2023
Q4 		$2.4K Buy
+233
New +$1.86K ﹤0.01% 6473
2022
Q1 		– Sell
-145
Closed -$1K – 7410
2021
Q4 		$1K Sell
145
-600
-81% -$7.79K ﹤0.01% 7218
2021
Q3 		$12K Buy
745
+45
+6% +$945 ﹤0.01% 6094
2021
Q2 		$17K Buy
+700
New +$16.2K ﹤0.01% 5753

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Osaic Holdings's NPCE Position: Q2 2026 in Review

Osaic Holdings increased its Neuropace (NPCE) stake by 56% in Q2 2026, buying an estimated $756 and bringing the position to 131 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #7264.

Osaic Holdings first reported a position in NPCE in Q2 2021 and has held it in 6 quarters since. The position peaked at $17K in Q2 2021. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Osaic Holdings held 131 shares of Neuropace worth $2.08K as of Q2 2026.
  • Osaic Holdings bought 47 Neuropace shares in Q2 2026, an estimated $756.
  • Neuropace made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7264 holding.
  • Osaic Holdings first reported a position in Neuropace in Q2 2021 and has held it in 6 quarters since.
  • Osaic Holdings's Neuropace position peaked at $17K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.